Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis.

Date publication

juin 2019

Journal

Histopathology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BIBEAU Frédéric

Tous les auteurs :
Solass W, Sempoux C, Carr NJ, Bibeau F, Neureiter D, Jäger T, Di Caterino T, Brunel C, Klieser E, Fristrup CW, Mortensen MB, Detlefsen S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30687944

Résumé

The four-tiered peritoneal regression grading score (PRGS) assesses the response to chemotherapy in peritoneal metastasis (PM). The PRGS is used, for example, to assess the response to pressurised intraperitoneal aerosol chemotherapy (PIPAC). However, the reproducibility of the PRGS is currently unknown. We aimed to evaluate the inter- and intraobserver variability of the PRGS.

Mots clés

colorectal cancer, gastric cancer, interobserver variability, ovarian cancer, pancreatic cancer, peritoneal metastasis, pressurised intraperitoneal aerosol chemotherapy, tumour regression grading

Référence

Histopathology. 2019 Jun;74(7):1014-1024